313 related articles for article (PubMed ID: 9096391)
1. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
3. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
[TBL] [Abstract][Full Text] [Related]
5. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
[TBL] [Abstract][Full Text] [Related]
7. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
[TBL] [Abstract][Full Text] [Related]
9. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.
Yoo S; Pettersson A; Jordahl KM; Lis RT; Lindstrom S; Meisner A; Nuttall EJ; Stack EC; Stampfer MJ; Kraft P; Brown M; Loda M; Giovannucci EL; Kantoff PW; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2027-31. PubMed ID: 24925673
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
13. South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
Krishnaswamy V; Kumarasamy T; Venkatesan V; Shroff S; Jayanth VR; Paul SFD
J Hum Genet; 2006; 51(3):254-257. PubMed ID: 16437189
[TBL] [Abstract][Full Text] [Related]
14. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.
Beilin J; Harewood L; Frydenberg M; Mameghan H; Martyres RF; Farish SJ; Yue C; Deam DR; Byron KA; Zajac JD
Cancer; 2001 Aug; 92(4):941-9. PubMed ID: 11550169
[TBL] [Abstract][Full Text] [Related]
17. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
[TBL] [Abstract][Full Text] [Related]
19. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
Mir K; Edwards J; Paterson PJ; Hehir M; Underwood MA; Bartlett JM
BJU Int; 2002 Oct; 90(6):573-8. PubMed ID: 12230620
[TBL] [Abstract][Full Text] [Related]
20. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
